Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost Delivery via Laser vs Microneedling in Alopecia Areata
NCT06239324Phase 2Recruiting
- Sponsor
- Egymedicalpedia
- Start
- Feb 2024
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of latanoprost in alopecia areata, sponsored by Egymedicalpedia. Primary endpoint: Hair regrowth evaluation at 3 months. Started Feb 2024; status: recruiting.
02
Drugs
latanoprost
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT06239324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06239324.